🇺🇸 FDA
Patent

US 10226426

Suspension containing nano-cocrystal and manufacturing method

granted A61KA61K31/341A61K31/405

Quick answer

US patent 10226426 (Suspension containing nano-cocrystal and manufacturing method) held by Takeda Pharmaceutical Company Limited expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/341, A61K31/405, A61K31/522, A61K31/55